-
Recent Advances in the Treatment of Advanced Urothelial Carcinoma: Insights from Dr. Jens Bedke
Platinum-based combination chemotherapy remains the cornerstone of treatment for advanced urothelial carcinoma (UC), but it still falls short of meeting long-term survival needs. At the 39th Annual Congress of the European Association of Urology (EAU24) held in Paris, France, Dr. Jens Bedke, from Klinikum Stuttgart Katharinen Hospital, shared the results of the EV-302/KEYNOTE-A39 study. Urology…
-
Professor Vasileios Sakalis on the Value of Artificial Intelligence in the Diagnosis and Treatment of Urological Tumors
Artificial Intelligence (AI) is transforming the diagnostic and treatment approaches for urological tumors, especially with significant advancements in intelligent imaging and pathology, potentially becoming an indispensable tool for clinicians. Dr. Vasileios Sakalis, a urologist from the Hippokrateion General Hospital of Thessaloniki, Greece, presented a comprehensive review on the application of AI in urological tumors at…
-
2024 CUDA Yanqi Lake Conference | Professor Xiongjun Ye Shares Recent Breakthroughs in Renal Cell Carcinoma Treatment
The ASCO-GU, a premier academic conference in urologic oncology, at the beginning of the year sparked academic enthusiasm in 2024, receiving over 140 abstracts related to renal cell carcinoma (RCC). Professor Xiongjun Ye from the Chinese Academy of Medical Sciences Cancer Hospital presented a report on the significant progress in RCC treatment from the ASCO-GU…
-
2024CUDA Conference | Professor Benkang Shi: Focus on Unmet Needs of mHSPC Patients, Achieve Stratified Treatment for Key Populations
The current treatment status of mHSPC patients in China and the need for further improvement have drawn attention. Recently, at the “4th Annual Conference of the Urology Physicians Branch of the Chinese Medical Association (2024)” held in Beijing, Professor Benkang Shi from Qilu Hospital of Shandong University shared insights on “Long-term Management of mHSPC Patients…
-
2024CUDA Conference | Professor Qiang Wei: Early Initiation of Novel Hormonal Therapy Brings More Benefits to Patients
The “4th Annual Conference of the Urology Physicians Branch of the Chinese Medical Association (2024)” was successfully held in Beijing from April 13th to 14th. During the conference, Professor Qiang Wei from West China Hospital, Sichuan University, shared insights on “Standard Treatment of mHSPC in the Era of Novel Hormonal Therapy.” Subsequently, “Oncology Frontier -…
-
BISC 2024丨Professor Junyan Qu: Interpretation of Anthrax Diagnosis and Treatment Plan (2023 Edition)
Anthrax is a zoonotic infectious disease caused by Bacillus anthracis infection, which still occurs sporadically in some areas of China. Anthrax can manifest in various clinical forms, with pulmonary anthrax having a mortality rate of over 80% and requiring management as a Class A infectious disease. In order to further standardize the clinical diagnosis and…
-
Professor Ning Shen ‘s Team: Mechanisms of Resistance to Cefiderocol in Highly Virulent Klebsiella pneumoniae | ESCMID Global 2024
With the escalating issue of antimicrobial resistance globally, newly emerged resistant strains pose a serious threat to public health. At the 34th European Congress of Clinical Microbiology and Infectious Diseases (ESCMID Global 2024), a study by Professor Ning Shen ‘s team from Peking University Third Hospital (Abstract No.: E0451) focused on the resistance issues of…
-
Professor Hongfei Duan：Advances in Diagnosis and Treatment of Mycobacterium avium Complex (MAC) Pulmonary Disease
Non-tuberculous mycobacteria (NTM) refers to all mycobacteria other than Mycobacterium tuberculosis and Mycobacterium leprae. NTM most commonly affect the lungs, causing NTM pulmonary disease (NTM-PD), which can even lead to disseminated disease in immunocompromised individuals. In recent years, with changes in the environment, updates in detection technology, and increased awareness among physicians, the incidence of…
Connecting Medical Expertise through Media